ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription and Caspase-1-Regulated IL-1β Secretion

Tang, Lipeng*; Li, Tong; Zhang, Bowen; Zhang, Zihao; Sun, Xiaoyi; Zhu, Ying; Feng, Bing; Su, Zuqing; Yang, Laijun; Li, Hongxia; Liu, Huazhen; Chen, Yuchao; Dai, Zhenhua; Zheng, Xirun; Li, Mingxian; Li, Chutian; Zhao, Jie; Qiu, Xinmin; Ye, Shuyan; Liu, Han; Zheng, Guangjuan*; Li, Ben*; Lu, Chuanjian*广东药学院; 广州大学; 广州中医药大学
Frontiers in Pharmacology2022-1-26DOI: 10.3389/fphar.2022.817526
9被引16阅读
引用收藏
分享

摘要

Psoriasis is a chronic and inflammatory skin disorder characterized by inflammation and epidermal hyperplasia. Punicalagin (PUN) is a main active ingredient of pomegranate (Punica granatum L.) peel with multiple biological activities, such as antibacterial, antioxidant and anti-tumor effects. However, the potential effect of PUN on psoriasis remains unknown. In this study, we want to investigate the pharmacological effect of PUN on psoriasis by using imiquimod (IMQ)-induced psoriatic mice model in vivo and tumor necrosis factor a (TNF-alpha) and interleukin-17A (IL-17A)-stimulated HaCaT cells in vitro. Our results showed that PUN can effectively alleviate the severity of psoriasis-like symptoms. Mechanistically, PUN potently suppresses the aberrant upregulation of interleukin-1 beta (IL-1 beta) and subsequent IL-1 beta-mediated inflammatory cascade in keratinocytes by inhibiting the nuclear factor kappa B (NF-kappa B) activation and cleaved caspase-1 expression in vitro and in vivo. Taken together, our findings indicate that PUN can relieve psoriasis by repressing NF-kappa B-mediated IL-1 beta transcription and caspase-1-regulated IL-1 beta secretion, which provide evidence that PUN might represent a novel and promising candidate for the treatment of psoriasis.

学科与关键词

关键词
psoriasispunicalaginNF-kappa Bcaspase-1IL-1 beta
相关
加载中…
  • P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways
    Chen, Haiming; Wang, Cheng; Tang, Bin; Yu, Jingjie; Lu, Yue; Zhang, Junhong; Yan, Yuhong; Deng, Hao; Han, Ling; Li, Shaoping*; Lu, Chuanjian*Frontiers in Pharmacology, 2022, 12: 806844.被引 4
  • Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression
    Tang, Lipeng; Zhang, Bowen; Li, Guanzhuo; Zhu, Ying; Feng, Bing; Su, Zuqing; Han, Wenhui; Huang, Huilin; Li, Qiuping; Wang, Maojie; Chen, Yuchao; Liu, Huazhen; Dai, Zhenhua; Wu, Dinghong; Li, Hongxia; Yang, Laijun; Lu, Yanjing; Ye, Zeting; Zheng, Guangjuan*Journal of Natural Medicines, 2023, 77(4): 712-720.被引 1
  • Apigenin ameliorates imiquimod-induced psoriasis in C57BL/6J mice by inactivating STAT3 and NF-KB
    Meng, Xianshe; Zheng, Shihong; Yin, Zequn; Wang, Xuerui; Yang, Daigang; Zou, Tingfeng; Li, Huaxin; Chen, Yuanli; Liao, Chenzhong*; Xie, Zhouling; Fan, Xiaodong; Han, Jihong; Duan, Yajun*; Yang, Xiaoxiao*Food Science and Human Wellness, 2024, 13(1): 211-224.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-01-26
卷期
第 13 卷
页码
817526
DOI
10.3389/fphar.2022.817526
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Joint Funding Project of Municipal Schools (Colleges) of Science and Technology Program of Guangzhou [202102010192]; Innovative and Enhancement Research Program of Guangdong Province under Grant [2019KTSCX025]; Specific Fund of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ23]; Science and Technology Planning Project of Guangzhou [201807010051, 202102021001]; Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Guangdong Provincial Clinical Research Center for Chinese Medicine Dermatology [2020B1111170012]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [YN2018QJ03, YN2019QJ07]; Specific Fund for the Administration of Traditional Chinese Medicine of Guangdong Province [20222066]

作者

  • T

    Tang, Lipeng (通讯) (第一作者)

    2 · guangzhou univ chinese med

  • L

    Li, Tong

    2 · guangzhou univ chinese med

查看全部 23 位作者收起作者
  • Z

    Zhang, Bowen

    2 · guangzhou univ chinese med

  • Z

    Zhang, Zihao

    guangdong pharmaceut univ

  • S

    Sun, Xiaoyi

    guangdong pharmaceut univ

  • Z

    Zhu, Ying

    2 · guangzhou univ chinese med

  • F

    Feng, Bing

    2 · guangzhou univ chinese med

  • S

    Su, Zuqing

    2 · guangzhou univ chinese med

  • Y

    Yang, Laijun

    2 · guangzhou univ chinese med

  • L

    Li, Hongxia

    2 · guangzhou univ chinese med

  • L

    Liu, Huazhen

  • C

    Chen, Yuchao

    guangdong prov acad chinese med sci

  • D

    Dai, Zhenhua

    guangdong prov acad chinese med sci

  • Z

    Zheng, Xirun

    2 · guangzhou univ chinese med

  • L

    Li, Mingxian

    2 · guangzhou univ chinese med

  • L

    Li, Chutian

    2 · guangzhou univ chinese med

  • Z

    Zhao, Jie

    2 · guangzhou univ chinese med

  • Q

    Qiu, Xinmin

    2 · guangzhou univ

  • Y

    Ye, Shuyan

    2 · guangzhou univ chinese med

  • L

    Liu, Han

  • Z

    Zheng, Guangjuan (通讯)

    2 · guangzhou univ chinese med

  • L

    Li, Ben (通讯)

    2 · guangzhou univ chinese med

  • L

    Lu, Chuanjian (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417